Other languages Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Delayed Japan Exchange Other stock markets 10:03:56 2024-05-06 pm EDT			5-day change	1st Jan Change
5,318 ^JPY	-3.34%		-0.97%	+37.19%

Apr. 30	Remsons, Daiichi Infotainments Form Joint Venture	MT
Apr. 29	AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Remsons, Daiichi Infotainments Form Joint Venture	Apr. 30
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	Apr. 29
AstraZeneca PLC and Daiichi Sankyo Announces ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Improved PFS in HER2-Low and Ultralow	Apr. 29
AstraZeneca makes progress with Truqap and Enhertu cancer treatments	Apr. 29
AstraZeneca's Breast Cancer Drug Improves Progression-free Survival in Late-stage Study	Apr. 29
Hipgnosis Songs Fund backs new Blackstone bid	Apr. 29
Scholz sichert Pharmabranche weiter Unterstützung zu	Apr. 25
Scholz verspricht Pharma-Branche bei Merck weitere Unterstützung	Apr. 25
Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	Apr. 25
AstraZeneca upbeat as cancer drugs underpin sales growth	Apr. 25
Le marché devient un peu timbré	Apr. 25
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...	Apr. 25
Daiichi Sankyo Company, Limited Announces Dividend for the Year Ended March 31, 2024, Payable on June 18, 2024 and Provides Dividend Guidance for Second Quarter of Fiscal Ending March 31, 2025	Apr. 25
Daiichi Sankyo Company, Limited Provides Dividend Guidance for Full Fiscal Ending March 31, 2025	Apr. 25
Daiichi Sankyo Company, Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	Apr. 25
Daiichi Sankyo Company, Limited announces an Equity Buyback for 55,000,000 shares, representing 2.87% for ¥200,000 million.	Apr. 25
Daiichi Sankyo Company, Limited authorizes a Buyback Plan.	Apr. 24
Pharmabranche erwartet Aufschwung - Standort Deutschland zunehmend gefragt	Apr. 24
Japon: le rejet en mer d'eau de Fukushima interrompu après un incident	Apr. 24
Middle East Tensions Dent Asian Stock Markets	Apr. 19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Other languages

Filters